Acorah Software Products - Accounts Production 15.0.600 false true false true No description of principal activity 1 February 2023 31 January 2024 31 January 2024 13867606 Mrs Naeema Atcha Mr Abdullah Bhana iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13867606 2023-01-31 13867606 2024-01-31 13867606 2023-02-01 2024-01-31 13867606 frs-core:CurrentFinancialInstruments 2024-01-31 13867606 frs-bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 13867606 frs-bus:FilletedAccounts 2023-02-01 2024-01-31 13867606 frs-bus:Micro-entities 2023-02-01 2024-01-31 13867606 frs-bus:AuditExemptWithAccountantsReport 2023-02-01 2024-01-31 13867606 frs-bus:Director1 2023-02-01 2024-01-31 13867606 frs-bus:Director2 2023-02-01 2024-01-31
Registered number: 13867606
Pharmabhana Limited
Unaudited Financial Statements
For The Year Ended 31 January 2024
Sam & Co Accountants
Accountant's Report
In accordance with the engagement letter dated , and in order to assist you to fulfil your duties under the Companies Act 2006, we have compiled the financial statements of the company from the accounting records and information and explanations you have given to us.
This report is made to the directors in accordance with the terms of our engagement. Our work has been undertaken to prepare for approval by the directors the financial statements that we have been engaged to compile, to report to the directors that we have done so, and to state those matters that we have agreed to state to them in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's directors for our work or for this report.
You have acknowledged on the balance sheet as at year ended 31 January 2024 your duty to ensure that the company has kept proper accounting records and to prepare financial statements that give a true and fair view under the Companies Act 2006. You consider that the company is exempt from the statutory requirement for an audit for the year.
We have not been instructed to carry out an audit of the financial statements. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the financial statements.
Signed
Sam and Co Accountants
21/10/2024
Sam & Co Accountants
MAAT membeship no :20422130 & ACPA Membership No: 01298415A
479 Chester Road
Old Trafford
Manchester
M16 9HF
Page 1
Balance Sheet
Registered number: 13867606
2024
£
Current assets 4,246
Creditors: Amounts Falling Due Within One Year (2,916 )
NET CURRENT ASSETS 1,330
TOTAL ASSETS LESS CURRENT LIABILITIES 1,330
NET ASSETS 1,330
CAPITAL AND RESERVES 1,330

Notes

1. General Information
Pharmabhana Limited is a private company, limited by shares, incorporated in England & Wales, registered number 13867606 . The registered office is 79 Humphrey Road, Manchester, M16 9DE.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
3. Directors Advances, Credits and Guarantees
Dividends paid to directors
2024
£
Mr Abdullah Bhana 2,800
Mrs Naeema Atcha 8,400
For the year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mrs Naeema Atcha
Director
Mr Abdullah Bhana
Director
21/10/2024